COALITION FOR ACCESS TO NCD MEDICINES & PRODUCTS
About the Coalition
The global, multisectoral Coalition for Access to NCD Medicines & Products was launched in 2017. This Coalition of government agencies, private-sector entities, nongovernmental organizations, philanthropic foundations, and academic institutions is dedicated to increasing access to medicines and health products for noncommunicable diseases (NCDs) to reduce the impact of diseases such as diabetes, hypertension, and cardiovascular disease.
Stay Up to Date
A global review of the availability and affordability of the 22 essential medicines and technologies for comprehensive diagnosis and treatment of diabetes, hypertension, and dyslipidemia in low-resource settings. A publication from the “No Empty Shelves: Diabetes Supplies, There When Needed” Project.
(Webinar Passcode: UvWJVr&3) Listen in as the Coalition for Access to NCD Medicines and Products and a panel of global experts (Dr. Dina Balabanova, John Fairhurst, Prof. Khama Rogo) moderated by Dr. Rachel Nugent explored opportunities for bold advocacy, research, and partnerships with the common goals of improving access to care and treatment for those living with NCDs, building future health system resiliency, and improving our preparedness for future pandemics.
Follow the Coalition's blog series for issues related to COVID-19 and access to NCD medicines and products.
- NCD Medicines and Products — Not Just Resource Limited, But Resource Variable
- Improving Access to NCD Medicines and Products Will Help Build Future Pandemic Resilience
- Taking Critical Action on NCDs during the COVID-19 Response and Beyond
- Exacerbated Supply Chain Challenges During the COVID-19 Crisis & Creative Solutions that Bring Hope for People Living with NCDs
Check out these tools and resources from the World Health Organization and the NCD Alliance to learn more about COVID-19 & NCDs.